The FDA has granted breakthrough device designation to SpinaFX Medical’s Triojection system, a minimally invasive treatment for contained lumbar disc herniations.

Philips (NYSE: PHG) announced today that it plans to invest more than $150 million in U.S. manufacturing and R&D efforts.

Simpson Interventions announced today that investigators completed the first cases in a trial of its Acolyte catheter system.